Press Resease

Chemotherapy Devices Market - Global Industry Analysis

Chemotherapy Devices Market by Product (Cannula, Pump, Catheter, and Others) and by End-User (Home Care, Clinics, and Hospitals): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 26-Dec-2018 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3672 Status : Published

Global chemotherapy devices market expected to generate around USD 18.8 billion by 2024, growing at a CAGR of around 7.9% between 2018 and 2024. Cancer is caused by uncontrolled and abnormal growth of cells. It can spread to other body parts and is one of the most fatal global diseases.

Description

The report covers a forecast and an analysis of the chemotherapy devices market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the chemotherapy devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the chemotherapy devices market on a global and regional level.

This report includes a comprehensive view of the Porter’s Five Forces model analysis for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Chemotherapy Devices Market

The report provides company market share analysis to give a broader overview of the key players of the chemotherapy devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the chemotherapy devices market on a global and regional basis.

The study provides a decisive view of the chemotherapy devices market by segmenting the market based on product, end-user, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on product, the chemotherapy devices market has been segmented into cannula, pump, catheter, and others. The end-user segment includes home care, clinics, and hospitals.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for chemotherapy devices based on individual segment and types in all the regions and countries.

Some key players of the chemotherapy devices market include Baxter International Inc., B. Braun Melsungen AG, Advanced Chemotherapy Technologies, Becton, Dickinson and Company, Halyard Health, Terumo Corporation, Fresenius Kabi, Moog Inc., Smiths Group PLC, Zyno Medical, and Micrel Medical Devices S.A.

This report segments the global chemotherapy devices market as follows:

Global Chemotherapy Devices Market: By Product

  • Cannula
  • Pump
  • Catheter
  • Others

Global Chemotherapy Devices Market: By End-User

  • Home Care
  • Clinics
  • Hospitals

Global Chemotherapy Devices Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Chemotherapy Devices market, 2017-2024(USD Billion)
    • 2.2. Global Chemotherapy Devices market: Snapshot
  •  
  • Chapter 3. Chemotherapy Devices Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Chemotherapy Devices market drivers: Impact analysis
      • 3.2.2. Rising occurrence of multiple types of cancers
      • 3.2.3. Growing stress on research and development in the oncology field
    • 3.3. Market Restraints
      • 3.3.1. Unwillingness shown by patients to undergo chemotherapy due to some discomfort
      • 3.3.2. A slight risk of infection caused due to chemotherapy
    • 3.4. Opportunities
      • 3.4.1. Efforts taken by various government and non-government organizations to increase cancer awareness
      • 3.4.2. Rapid technological advancement
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by End-User
  •  
  • Chapter 4. Global Chemotherapy Devices Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Chemotherapy Devices market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Chemotherapy Devices Market - Product Segment Analysis
    • 5.1. Global Chemotherapy Devices market: Product overview
      • 5.1.1. Global Chemotherapy Devices market revenue share, by Product, 2017 and 2024
    • 5.2. Cannula
      • 5.2.1. Global Chemotherapy Devices market for Cannula, 2017 - 2024(USD Billion)
    • 5.3. Pump
      • 5.3.1. Global Chemotherapy Devices market for Pump, 2017 - 2024(USD Billion)
    • 5.4. Catheter
      • 5.4.1. Global Chemotherapy Devices market for Catheter, 2017 - 2024 (USD Billion)
    • 5.5. Others
      • 5.5.1. Global Chemotherapy Devices market for Others, 2017 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Chemotherapy Devices Market - End-User Segment Analysis
    • 6.1. Global Chemotherapy Devices market: End-User overview
      • 6.1.1. Global Chemotherapy Devices market revenue share, by End-User, 2017 and 2024
    • 6.2. Home Care
      • 6.2.1. Global Chemotherapy Devices market for Home Care, 2017 - 2024 (USD Billion)
    • 6.3. Clinics
      • 6.3.1. Global Chemotherapy Devices market for Clinics, 2017 - 2024 (USD Billion)
    • 6.4. Hospitals
      • 6.4.1. Global Chemotherapy Devices market for Hospitals, 2017 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Chemotherapy Devices Market - Regional Segment Analysis
    • 7.1. Global Chemotherapy Devices market: Regional overview
      • 7.1.1. Global Chemotherapy Devices market revenue share, by region, 2017 and 2024
    • 7.2. North America
      • 7.2.1. North America Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
      • 7.2.2. North America Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.2.3.2. The U.S. Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.2.4. Canada
        • 7.2.4.1. Canada Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.2.4.2. Canada Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.2.5.2. Rest of North America Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
      • 7.3.2. Europe Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.3.3.2. Germany Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.4. UK
        • 7.3.4.1. U.K. Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.3.4.2. U.K. Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.3.5.2. France Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.6. Italy
        • 7.3.6.1. Italy Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.3.6.2. Italy Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.7. Spain
        • 7.3.7.1. Spain Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.3.7.2. Spain Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.8. Russia
        • 7.3.8.1. Russia Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.3.8.2. Russia Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.3.9. Rest of Europe
        • 7.3.9.1. Rest of Europe Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.3.9.2. Rest of Europe Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
      • 7.4.2. Asia Pacific Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.4.3.2. China Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.4.4.2. Japan Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.4.5.2. India Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.6. Australia
        • 7.4.6.1. Australia Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.4.6.2. Australia Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.4.7.2. Rest of Asia Pacific Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
      • 7.5.2. Latin America Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.5.3.2. Brazil Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.5.4. Mexico
        • 7.5.4.1. Mexico Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.5.4.2. Mexico Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.5.5. Argentina
        • 7.5.5.1. Argentina Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.5.5.2. Argentina Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.5.6. Rest of Latin America
        • 7.5.6.1. Rest of Latin America Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
        • 7.5.6.2. Rest of Latin America Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Chemotherapy Devices market revenue, by Product, 2017 - 2024(USD Billion)
      • 7.6.2. The Middle East and Africa Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.6.3. Saudi Arabia
        • 7.6.3.1. Saudi Arabia Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.6.3.2. Saudi Arabia Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.6.4. UAE
        • 7.6.4.1. UAE Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.6.4.2. UAE Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.6.5. South Africa
        • 7.6.5.1. South Africa Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.6.5.2. South Africa Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.6.6. Qatar
        • 7.6.6.1. Qatar Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.6.6.2. Qatar Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
      • 7.6.7. Rest of the Middle East and Africa
        • 7.6.7.1. Rest of the Middle East and Africa Chemotherapy Devices market revenue, by Product, 2017 - 2024 (USD Billion)
        • 7.6.7.2. Rest of the Middle East and Africa Chemotherapy Devices market revenue, by End-User, 2017 - 2024 (USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Baxter International Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. B. Braun Melsungen AG
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Advanced Chemotherapy Technologies
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Becton, Dickinson and Company
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Halyard Health
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Terumo Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Fresenius Kabi
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Moog Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Smiths Group PLC
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Therapy portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Zyno Medical
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Therapy portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments
    • 8.11. Micrel Medical Devices S.A.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Therapy portfolio
      • 8.11.4. Business strategy
      • 8.11.5. Recent developments

Methodology

Free Analysis

Cancer is caused by uncontrolled and abnormal growth of cells. There are more than 100 types of cancer in the world. It can spread to other body parts and is one of the most fatal global diseases. Tobacco is responsible for around 33% of cancer cases worldwide. Poor diet, obesity, excessive alcohol consumption, and low physical activity are responsible for around 10% of cancer cases. Exposure to environmental pollutants and ionizing radiation are responsible for cancer. Inherited genetic can also cause cancer. Cancer can be treated by using several techniques, such as surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy, targeted therapy, stem cell therapy, and precision medicine.

The rising occurrences of multiple cancer types, such as sarcoma, lung cancer, lymphoma, myeloma, and breast cancer, are likely to act as the major growth driver for the chemotherapy devices market globally. Cancer is the second prominent cause of death globally. According to the Cancer Research UK, cancer was caused almost 9.6 million deaths worldwide in 2018. It further stated that around 17 million new cancer cases were registered in 2018. Furthermore, around 1.7 million new cancer cases are to be detected in the U.S. and more than 6,00,000 people will succumb to the disease in 2018. Furthermore, growing stress on research and development in oncology and the rising demand for precise and biological drug therapies are likely to propel this market in the future. Efforts taken by various government and non-government organizations to increase cancer awareness and rapid technological advancements are anticipated to create opportunities for the chemotherapy devices market players. However, unwillingness showed by patients to undergo chemotherapy, slight risk of infection due to chemotherapy, and the absence of insurance and reimbursement policies in developing regions might limit this market globally.

Global Chemotherapy Devices Market

The global chemotherapy devices market has been segmented into product and end-user. By product, the chemotherapy devices market includes cannula, pump, catheter, and others. The end-user segment is divided into home care, clinics, and hospitals.

By region, Europe is likely to be the prominent region in the forecast time period. The increasing number of geriatric population, growing government expenditure on chemotherapy procedures through the National Health Service (NHS), and rapid technological advancements are likely to boost this regional market. The North American region is projected to generate substantial revenue in the future, due to the increasing occurrences of multiple types of cancers and the rising presence of highly developed healthcare infrastructure. The Asia Pacific chemotherapy devices market is anticipated to grow rapidly in the upcoming years. Rising awareness regarding cancer diagnosis and treatment, high use of tobacco and other cancer-causing agents, and rising per capita healthcare spending are expected to boost this regional market in the projected timeframe.

Some key players of the chemotherapy devices market include Baxter International Inc., B. Braun Melsungen AG, Advanced Chemotherapy Technologies, Becton, Dickinson and Company, Halyard Health, Terumo Corporation, Fresenius Kabi, Moog Inc., Smiths Group PLC, Zyno Medical, and Micrel Medical Devices S.A.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social